Investment
Features
FeesSafety
Academy
More
Pluang+

Deep Fission IPO values company near $1B, offering potential 3-16x upside with fast reactor tech and strong partnerships.

Market News
17 Jun 2026
Seeking Alpha
View Source
Bullish
pluang ai news

Deep Fission, Inc. plans to go public on June 18, 2026, with an IPO valuing the company at about $1 billion, which is a discount compared to similar small modular reactor (SMR) peers. The company's innovative gravity-based borehole reactor design allows for faster six-month build times and lower costs ($2.5–$3 billion per GW), while avoiding advanced fuel supply risks. Deep Fission has a 15 GW project pipeline and strategic partnerships with Halliburton, Blue Owl, and Goldman Sachs, plus support from the Department of Energy for pilot projects, positioning it for rapid commercialization. If the company executes well and closes the valuation gap, investors could see a 3 to 16 times return, making the IPO an attractive risk/reward opportunity.

More News

Barclays raises Hudbay Minerals price target to $32 on strong copper growth outlook.

Barclays raises Hudbay Minerals price target to $32 on strong copper growth outlook.

Barclays increased its price target for Hudbay Minerals to $32 from $30, citing strong growth prospects in copper mining. Despite a recent nearly 30% stock pullback due to market sentiment, Hudbay maintains a solid financial position with near-zero n...

Analyst Insights
Bullish
46 minutes ago
Morgan Stanley beats Q2 earnings and revenue estimates with strong divisional growth.

Morgan Stanley beats Q2 earnings and revenue estimates with strong divisional growth.

Morgan Stanley reported strong Q2 2026 results, with earnings per share of $3.46 surpassing estimates of $2.89 and revenue of $21.35 billion beating forecasts of $19.67 billion. This marks significant year-over-year growth from $16.79 billion, driven...

Company Fundamentals
Bullish
49 minutes ago
Autoimmune therapeutics market to reach $137.85B by 2035, driven by biologics and precision medicine growth

Autoimmune therapeutics market to reach $137.85B by 2035, driven by biologics and precision medicine growth

The global autoimmune disease therapeutics market is projected to grow from $80.54 billion in 2025 to $137.85 billion by 2035, at a CAGR of 5.52%. Growth is fueled by rising autoimmune disease prevalence, advances in biologics, JAK inhibitors, monocl...

Market News
Bullish
50 minutes ago
Light Up Chinatown! 2026 festival returns to Vancouver with food, music, and community events on August 8-9.

Light Up Chinatown! 2026 festival returns to Vancouver with food, music, and community events on August 8-9.

The Vancouver Chinatown Foundation and RBC are hosting Light Up Chinatown! 2026, a free two-day festival on August 8-9 along Columbia Street in Vancouver’s Chinatown. The event features exclusive food collaborations, live music performances, family a...

Others
Neutral
50 minutes ago
Travelers are more strategic with rewards programs, seeking value and ease amid rising loyalty challenges.

Travelers are more strategic with rewards programs, seeking value and ease amid rising loyalty challenges.

New research from iSeatz reveals that U.S. travelers are increasingly strategic about travel rewards programs, with 40% treating them as financial optimization tools and 60% belonging to multiple programs. Despite high enrollment, many travelers find...

Others
Neutral
50 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App